Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
The racial disparities that exist in triple-negative breast cancer incidence and outcomes are well known. Could neighborhood circumstances contribute to these inequities?
Certain reproductive factors are known to influence the risk for breast cancer. What is known about the association between these factors and breast tissue composition?
A better understanding of the impacts of neoadjuvant chemotherapy on the immune microenvironment could have important prognostic implications in triple-negative breast cancer.
Did patients with locally advanced or metastatic breast cancer realize improvements in progression-free survival after treatment with this triple combination therapy?
Navitoclax used in combination with EGFR-targeted ADCs could present a potential new treatment option for EGFR-expressing triple-negative breast cancer.
Recent developments in our understanding of quadruple-negative breast cancer could have important implications for therapy development and future research.
Is there an association between obesity and treatment response? A study examined the potential impacts of BMI among breast cancer patients receiving neo-adjuvant anti-HER2 therapies.
Mission Statement:
Breast Cancer Research
is a multidisciplinary journal edited by Bruce Ponder, Lewis Chodosh, Stephen Johnston and an international editorial board.
